Arcline Investment Management’s portfolio company Medical Manufacturing Technologies (MMT) has acquired GenX Medical to bolster its extrusion portfolio and speciality manufacturing services.

Financial details of the acquisition were not disclosed.

GenX Medical is a US-based supplier of custom medical tubing, specialising in tubing and custom extrusions for the medical device industry.

Founded in 2015, the company delivers micro-bore tubing, bioresorbable extrusions, and complex custom solutions.

According to MMT, the acquisition of GenX Medical aligns with its mission to advance medical device manufacturing processes.

The integration of GenX’s expertise will enhance MMT’s manufacturing equipment and applications.

The acquisition also expands MMT’s portfolio, enhancing its end-to-end manufacturing services.

By offering advanced extrusions, Medical Manufacturing Technologies aims to meet the evolving needs of medical device manufacturers. This expanded solution provides global manufacturers with the expertise and support needed for operational success.

GenX Medical president and owner Tyler Ware said: “We are excited to join forces with MMT.

“By leveraging our combined strengths and capabilities, we aim to deliver cutting-edge solutions that will benefit our customers, drive further successes in manufacturing and positively impact patients worldwide.”

Ware will assume the role of technical director, joining MMT’s technical leadership team.

The acquisition of GenX Medical marks MMT’s ninth acquisition and its 11th brand.

In May 2023, Medical Manufacturing Technologies acquired Somex Automation, an Irish provider of custom automation equipment and processes.

Its portfolio also includes CATHTIP, Engineering by Design, Glebar, Interface Catheter Solutions, MMT Automation, MPT Europe, R&D Engineering, SYNEO, and Tridex Technology.

MMT CEO Robbie Atkinson said: “We are thrilled to add GenX Medical to our manufacturing services platform and proud to welcome a talented team of committed manufacturing experts.

“Together, we will continue to deliver exceptional products and services that drive innovation in our industry.

“This acquisition underscores our commitment to advancing medical device manufacturing innovations and allows us to further provide efficient and cost-effective solutions to customers worldwide.”